diabetic autonomic neuropathy
Summary
Diabetic autonomic neuropathy (DAN) is a chronic complication of diabetes mellitus caused by damage to autonomic (sympathetic and parasympathetic) nerve fibers, resulting in dysfunction of cardiovascular, gastrointestinal, genitourinary, and sudomotor systems. It commonly presents with resting tachycardia, orthostatic hypotension, gastroparesis, and erectile dysfunction. It is associated with increased cardiovascular mortality and is a marker of poor glycemic control duration.
Detail
Pathophysiology: Chronic hyperglycemia leads to polyol pathway activation, advanced glycation end-product (AGE) formation, oxidative stress, and microvascular ischemia (vasa nervorum damage), causing progressive axonal degeneration of both sympathetic and parasympathetic autonomic fibers. Small unmyelinated C-fibers are affected early.
Clinical manifestations by system: - Cardiovascular: Resting tachycardia (loss of vagal tone), orthostatic hypotension (sympathetic denervation causing failure of vasoconstriction), reduced heart rate variability, silent myocardial ischemia (blunted anginal pain perception - dangerous, may present with painless MI), and increased risk of sudden cardiac death. - Gastrointestinal: Gastroparesis (delayed gastric emptying causing early satiety, nausea, vomiting, erratic glucose control), esophageal dysmotility, diabetic diarrhea (often nocturnal, alternating with constipation), fecal incontinence. - Genitourinary: Erectile dysfunction (very common, often an early sign), retrograde ejaculation, neurogenic bladder (detrusor dysfunction leading to incomplete emptying, urinary retention, recurrent UTIs). - Sudomotor: Anhidrosis of extremities with compensatory truncal hyperhidrosis, gustatory sweating. - Pupillary: Decreased pupillary light reflex.
Diagnosis: Clinical suspicion in long-standing diabetics with poor glycemic control. Cardiovascular autonomic testing includes heart rate response to deep breathing, Valsalva maneuver, and postural blood pressure changes (orthostatic vitals - drop in systolic BP ≥20 mmHg or diastolic ≥10 mmHg upon standing). Gastric emptying studies for suspected gastroparesis.
Management: Primarily glycemic control to slow progression (though existing damage often irreversible). Symptomatic treatment: fludrocortisone or midodrine for orthostatic hypotension; metoclopramide or erythromycin for gastroparesis; sildenafil for ED; bethanechol for neurogenic bladder. Patient education regarding fall risk and silent ischemia.
Clinical significance: DAN is an independent risk factor for mortality in diabetic patients, largely due to silent MI and sudden cardiac death from cardiac autonomic denervation. Screening is recommended in patients with longstanding type 1 diabetes (>5 years) or any type 2 diabetes at diagnosis.
Sources
- Harrison's Principles of Internal Medicine
- First Aid for the USMLE Step 1
- Robbins Basic Pathology
- UpToDate: Diabetic autonomic neuropathy
- American Diabetes Association Standards of Medical Care in Diabetes
Reviewed by AnkiBoss editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.